Clinical trial registration and reporting: a survey of academic organizations in the United States
Abstract Background Many clinical trials conducted by academic organizations are not published, or are not published completely. Following the US Food and Drug Administration Amendments Act of 2007, “The Final Rule” (compliance date April 18, 2017) and a National Institutes of Health policy clarifie...
Main Authors: | Evan Mayo-Wilson, James Heyward, Anthony Keyes, Jesse Reynolds, Sarah White, Nidhi Atri, G. Caleb Alexander, Audrey Omar, Daniel E. Ford, on behalf of the National Clinical Trials Registration and Results Reporting Taskforce Survey Subcommittee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-018-1042-6 |
Similar Items
-
Registration of phase 3 crossover trials on ClinicalTrials.gov
by: Lijuan Zeng, et al.
Published: (2020-07-01) -
Registration of published randomized trials: a systematic review and meta-analysis
by: Ludovic Trinquart, et al.
Published: (2018-10-01) -
Adherence to the International Committee of Medical Journal Editors’ (ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of trials published in high-impact specialty society journals
by: Anand D. Gopal, et al.
Published: (2018-08-01) -
Overcoming non-compliance with clinical trial registration and results reporting: One Institution's approach
by: Sarah H. Snider, et al.
Published: (2020-06-01) -
A systematic review of the processes used to link clinical trial registrations to their published results
by: Rabia Bashir, et al.
Published: (2017-07-01)